We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As pressure grows for comprehensive reform of Puerto Rico's public finances, local reports have highlighted possible lost revenue as U.S. tax measures attract drug firms' capital back home.
Cancer drug developer Peregrine Pharmaceuticals Inc. said Thursday that it licensed certain rights to its tumor-targeting technology to biopharmaceutical company Medarex Inc.
Brazil's health minister signed a memorandum of understanding with the Clinton Foundation that would allow the country to obtain anti-Aids medicines more cheaply.
Grandix Pharmaceuticals Ltd. said Friday that the company has tied up with Italian diagnostics major Chromogenix for distributing select products in India.
Inyx, Inc. (OTC Bulletin Board: IYXI), a specialty pharmaceutical company with a focus on niche drug delivery technologies and products, announced today that it and UCB, a global biopharmaceutical company headquartered in Brussels, Belgium, have signed a definitive agreement whereby Inyx will acquire from UCB all the outstanding shares of Celltech Manufacturing Services Limited (CMSL), a UCB subsidiary based in Ashton, England.
While the pharmaceuticals industry is lobbying to get the existing list of the 76 bulk drugs outside the Drug Price Control Order (DPCO), Chemicals and Fertilisers Minister Ram Vilas Paswan is keen on extending the list to cover 354 bulk drugs, which in effect will cover most of the industry.